Get the Stockscreener App
1.16
1.69%
-0.02
After Hours:
1.20
0.04
+3.45%
Pds Biotechnology Corporation stock is traded at $1.16, with a volume of 384.21K.
It is down -1.69% in the last 24 hours and down -5.69% over the past month.
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
See More
Previous Close:
$1.18
Open:
$1.17
24h Volume:
384.21K
Relative Volume:
0.80
Market Cap:
$54.55M
Revenue:
-
Net Income/Loss:
$-40.56M
P/E Ratio:
-0.9915
EPS:
-1.17
Net Cash Flow:
$-35.28M
1W Performance:
-3.33%
1M Performance:
-5.69%
6M Performance:
-2.52%
1Y Performance:
-61.97%
1-Day Range:
$1.15
$1.20
1-Week Range:
$1.13
$1.2605
52-Week Range:
$0.8505
$4.29
Pds Biotechnology Corporation Stock (PDSB) Company Profile
Name
Pds Biotechnology Corporation
Sector
Industry
Phone
800-208-3343
Address
303A COLLEGE ROAD EAST, PRINCETON
Compare PDSB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PDSB
Pds Biotechnology Corporation
|
1.16 | 57.84M | 0 | -40.56M | -35.28M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Pds Biotechnology Corporation Stock (PDSB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-01-22 | Initiated | B. Riley Securities | Buy |
| Jun-28-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-10-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| May-27-20 | Initiated | Alliance Global Partners | Buy |
| Mar-09-20 | Initiated | Noble Capital Markets | Outperform |
| Oct-24-19 | Initiated | Chardan Capital Markets | Buy |
View All
Pds Biotechnology Corporation Stock (PDSB) Latest News
How to monitor PDS Biotechnology Corporation with trend dashboardsEarnings Overview Report & Capital Efficiency Focused Strategies - Newser
Can swing trading help recover from PDS Biotechnology Corporation lossesBear Alert & AI Enhanced Trade Execution Alerts - Newser
Is it too late to sell PDS Biotechnology Corporation2025 Market Overview & Community Consensus Stock Picks - Newser
how to monitor pds biotechnology corporation with trend dashboardsWeekly Volume Report & Entry Point Confirmation Signals - Newser
Custom watchlist performance reports with PDS Biotechnology CorporationAnalyst Upgrade & High Accuracy Swing Trade Signals - Newser
Is PDS Biotechnology Corporation building a consolidation baseShare Buyback & Accurate Entry and Exit Point Alerts - Newser
Tools to monitor PDS Biotechnology Corporation recovery probabilityFed Meeting & Daily Chart Pattern Signal Reports - Newser
Published on: 2025-09-12 13:48:31 - Newser
Is PDS Biotechnology Corporation still worth holding after the dipJuly 2025 Pullbacks & Capital Efficient Trade Techniques - Newser
Key metrics from PDS Biotechnology Corporation’s quarterly dataMarket Growth Summary & AI Optimized Trade Strategies - Newser
Using RSI to spot recovery in PDS Biotechnology CorporationPortfolio Risk Report & Comprehensive Market Scan Insights - Newser
Published on: 2025-09-12 12:57:47 - Newser
Volume spikes in PDS Biotechnology Corporation stock – what they meanBuy Signal & Precise Swing Trade Alerts - Newser
PDS Biotechnology Corporation stock trendline breakdownMarket Sentiment Report & Growth Focused Stock Reports - Newser
Real time pattern detection on PDS Biotechnology Corporation stockJuly 2025 Catalysts & Reliable Price Action Trade Plans - Newser
Is PDS Biotechnology Corporation forming a bottoming baseWeekly Trend Summary & Technical Entry and Exit Tips - Newser
Using economic indicators to assess PDS Biotechnology Corporation potentialJuly 2025 Macro Moves & Smart Allocation Stock Reports - Newser
Is now a turning point for PDS Biotechnology CorporationDividend Hike & Reliable Trade Execution Plans - Newser
Will PDS Biotechnology Corporation bounce back from current supportTrade Volume Report & Community Consensus Stock Picks - Newser
how to track smart money flows in pds biotechnology corporationJuly 2025 Review & Technical Analysis for Trade Confirmation - Newser
Tick level data insight on PDS Biotechnology Corporation volatilityMarket Weekly Review & Verified Swing Trading Watchlist - Newser
What MACD and RSI say about PDS Biotechnology CorporationJuly 2025 Trends & Short-Term Swing Trade Alerts - Newser
Reversal indicators forming on PDS Biotechnology Corporation stock2025 Price Targets & AI Enhanced Trading Signals - Newser
Exit strategy if you’re trapped in PDS Biotechnology CorporationInflation Watch & Smart Money Movement Alerts - Newser
Can PDS Biotechnology Corporation recover in the next quarter2025 Stock Rankings & Weekly Setup with ROI Potential - Newser
Institutional scanner results for PDS Biotechnology CorporationMarket Movement Recap & Risk Controlled Swing Trade Alerts - Newser
How to track smart money flows in PDS Biotechnology CorporationTrade Risk Assessment & Weekly High Momentum Picks - Newser
How high can PDS Biotechnology Corporation stock goJuly 2025 Highlights & Reliable Breakout Forecasts - Newser
Is PDS Biotechnology Corporation meeting your algorithmic filter criteriaEarnings Beat & Free Weekly Watchlist of Top Performers - Newser
Using Ichimoku Cloud for PDS Biotechnology Corporation technicalsEarnings Growth Report & Pattern Based Trade Signal System - Newser
using data tools to time your pds biotechnology corporation exit2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
What does recent volatility data suggest for PDS Biotechnology CorporationVolume Spike & Daily Growth Stock Tips - Newser
Published on: 2025-09-11 00:30:19 - Newser
Can you recover from losses in PDS Biotechnology CorporationTrade Volume Report & High Conviction Trade Alerts - Newser
Will breakout in PDS Biotechnology Corporation lead to full recoveryTrend Reversal & Smart Allocation Stock Tips - Newser
Short interest data insights for PDS Biotechnology CorporationMarket Sentiment Review & Free Safe Capital Growth Stock Tips - Newser
Pds Biotechnology Corporation Stock (PDSB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):